Managed Care Calendar
- AAPM 2010 Clinical Meeting
Poll
Issue
- Issue:October 2009
First to Demonstrate Some Effectiveness in Humans
Since the emergence of the human immunodeficiency virus/acquired immune deficiency syndrome (HIV/AIDS) >25 years ago, there have been significant advances in testing for and treating the disease, as well as massive educational campaigns to encourage prevention. Despite these efforts, along with improved treatment with combination antiretroviral drug regimens, the number of cases continues to grow. Researchers have been mostly unsuccessful in developing a vaccine to prevent the spread of HIV/AIDS, but t
REQUIP XL is an oral dopamine agonist medication for Parkinson’s disease and had demonstrated significant improvement in the symptoms of Parkinson’s disease.
The Role of Immune Function in the Changing Landscape of RRMS Therapies
Gastroesophageal reflux disease (GERD) is an important
managed care health concern because it is one of the most common gastrointestinal (GI) disorders in the United
States. GERD affects nearly 18.6 million Americans, according to a national healthcare database analysis.
Parkinson’s disease (PD) is a progressive
and disabling neurologic disorder. The disease is the most prevalent type of parkinsonism, a clinical syndrome caused by lesions in the basal ganglia, predominantly in the substantia nigra, which produces deficits in motor behavior.
